nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Blindness—Lisinopril—dilated cardiomyopathy	0.00903	0.0846	CcSEcCtD
Trihexyphenidyl—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00685	0.0642	CcSEcCtD
Trihexyphenidyl—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00637	0.0597	CcSEcCtD
Trihexyphenidyl—Confusional state—Spironolactone—dilated cardiomyopathy	0.00441	0.0413	CcSEcCtD
Trihexyphenidyl—Somnolence—Spironolactone—dilated cardiomyopathy	0.00388	0.0364	CcSEcCtD
Trihexyphenidyl—Drowsiness—Furosemide—dilated cardiomyopathy	0.00373	0.0349	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0036	0.0337	CcSEcCtD
Trihexyphenidyl—Dizziness—Spironolactone—dilated cardiomyopathy	0.00289	0.0271	CcSEcCtD
Trihexyphenidyl—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00284	0.0266	CcSEcCtD
Trihexyphenidyl—Vomiting—Spironolactone—dilated cardiomyopathy	0.00278	0.026	CcSEcCtD
Trihexyphenidyl—Rash—Spironolactone—dilated cardiomyopathy	0.00275	0.0258	CcSEcCtD
Trihexyphenidyl—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00275	0.0258	CcSEcCtD
Trihexyphenidyl—Vision blurred—Furosemide—dilated cardiomyopathy	0.00275	0.0257	CcSEcCtD
Trihexyphenidyl—Headache—Spironolactone—dilated cardiomyopathy	0.00274	0.0256	CcSEcCtD
Trihexyphenidyl—Agitation—Furosemide—dilated cardiomyopathy	0.00268	0.0251	CcSEcCtD
Trihexyphenidyl—Nausea—Spironolactone—dilated cardiomyopathy	0.0026	0.0243	CcSEcCtD
Trihexyphenidyl—Hallucination—Lisinopril—dilated cardiomyopathy	0.0025	0.0234	CcSEcCtD
Trihexyphenidyl—Confusional state—Furosemide—dilated cardiomyopathy	0.0024	0.0224	CcSEcCtD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00231	0.00259	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00231	0.00259	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00231	0.00258	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00229	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00228	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00228	0.00256	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00228	0.00255	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00228	0.00255	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00226	0.00253	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00225	0.00252	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00224	0.00251	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00223	0.00249	CbGpPWpGaD
Trihexyphenidyl—CHRM4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00222	0.00249	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00222	0.00248	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00221	0.00248	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0022	0.00246	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0022	0.00246	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00219	0.00246	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00219	0.00246	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00217	0.00243	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00217	0.00243	CbGpPWpGaD
Trihexyphenidyl—Tension—Lisinopril—dilated cardiomyopathy	0.00214	0.0201	CcSEcCtD
Trihexyphenidyl—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00214	0.0024	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00213	0.00238	CbGpPWpGaD
Trihexyphenidyl—Nervousness—Lisinopril—dilated cardiomyopathy	0.00212	0.0199	CcSEcCtD
Trihexyphenidyl—Somnolence—Furosemide—dilated cardiomyopathy	0.00211	0.0198	CcSEcCtD
Trihexyphenidyl—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00206	0.0193	CcSEcCtD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00205	0.00229	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00204	0.00228	CbGpPWpGaD
Trihexyphenidyl—Constipation—Furosemide—dilated cardiomyopathy	0.00203	0.019	CcSEcCtD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00202	0.00226	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00198	0.00222	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00198	0.00221	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00198	0.00221	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00197	0.0022	CbGpPWpGaD
Trihexyphenidyl—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00196	0.0183	CcSEcCtD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00196	0.00219	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00195	0.00218	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00191	0.00214	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00187	0.0021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00187	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00185	0.00207	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00183	0.00205	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00181	0.00203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00181	0.00203	CbGpPWpGaD
Trihexyphenidyl—Confusional state—Lisinopril—dilated cardiomyopathy	0.0018	0.0168	CcSEcCtD
Trihexyphenidyl—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0018	0.00201	CbGpPWpGaD
Trihexyphenidyl—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00179	0.00201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00177	0.00198	CbGpPWpGaD
Trihexyphenidyl—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00174	0.0163	CcSEcCtD
Trihexyphenidyl—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00174	0.00194	CbGpPWpGaD
Trihexyphenidyl—Asthenia—Furosemide—dilated cardiomyopathy	0.00171	0.016	CcSEcCtD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00169	0.00189	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00169	0.00189	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00169	0.00189	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00168	0.00188	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00168	0.00188	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00167	0.00187	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00167	0.00187	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00167	0.00187	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00165	0.00185	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00165	0.00185	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00162	0.00181	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00161	0.0018	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00161	0.0018	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.0016	0.00179	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0016	0.00179	CbGpPWpGaD
Trihexyphenidyl—Somnolence—Lisinopril—dilated cardiomyopathy	0.00159	0.0149	CcSEcCtD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00159	0.00177	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00158	0.00177	CbGpPWpGaD
Trihexyphenidyl—Dizziness—Furosemide—dilated cardiomyopathy	0.00157	0.0147	CcSEcCtD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00156	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00155	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00154	0.00172	CbGpPWpGaD
Trihexyphenidyl—Constipation—Lisinopril—dilated cardiomyopathy	0.00153	0.0143	CcSEcCtD
Trihexyphenidyl—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00152	0.0017	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.00152	0.0017	CbGpPWpGaD
Trihexyphenidyl—Vomiting—Furosemide—dilated cardiomyopathy	0.00151	0.0142	CcSEcCtD
Trihexyphenidyl—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00151	0.00169	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0015	0.00168	CbGpPWpGaD
Trihexyphenidyl—Rash—Furosemide—dilated cardiomyopathy	0.0015	0.014	CcSEcCtD
Trihexyphenidyl—Dermatitis—Furosemide—dilated cardiomyopathy	0.0015	0.014	CcSEcCtD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0015	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00149	0.00167	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00149	0.00167	CbGpPWpGaD
Trihexyphenidyl—Headache—Furosemide—dilated cardiomyopathy	0.00149	0.0139	CcSEcCtD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00148	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00148	0.00165	CbGpPWpGaD
Trihexyphenidyl—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00147	0.0138	CcSEcCtD
Trihexyphenidyl—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00146	0.00163	CbGpPWpGaD
Trihexyphenidyl—Nausea—Furosemide—dilated cardiomyopathy	0.00141	0.0132	CcSEcCtD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0014	0.00157	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0014	0.00157	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.00138	0.00154	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00135	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00135	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00134	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00131	0.00146	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00129	0.00144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00129	0.00144	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00128	0.00144	CbGpPWpGaD
Trihexyphenidyl—Asthenia—Lisinopril—dilated cardiomyopathy	0.00128	0.012	CcSEcCtD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00128	0.00143	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00128	0.00143	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00127	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00126	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00125	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00122	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00122	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00122	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00122	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00121	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00121	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00119	0.00133	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00119	0.00133	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00119	0.00133	CbGpPWpGaD
Trihexyphenidyl—Dizziness—Lisinopril—dilated cardiomyopathy	0.00118	0.011	CcSEcCtD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00118	0.00132	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00115	0.00129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00114	0.00127	CbGpPWpGaD
Trihexyphenidyl—Vomiting—Lisinopril—dilated cardiomyopathy	0.00113	0.0106	CcSEcCtD
Trihexyphenidyl—Rash—Lisinopril—dilated cardiomyopathy	0.00112	0.0105	CcSEcCtD
Trihexyphenidyl—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00112	0.0105	CcSEcCtD
Trihexyphenidyl—Headache—Lisinopril—dilated cardiomyopathy	0.00112	0.0105	CcSEcCtD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00112	0.00125	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00111	0.00125	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0011	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00109	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00108	0.00121	CbGpPWpGaD
Trihexyphenidyl—Nausea—Lisinopril—dilated cardiomyopathy	0.00106	0.00992	CcSEcCtD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00103	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00103	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00102	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00102	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00101	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000981	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000981	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000947	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000947	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000944	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000944	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000939	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000935	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000935	0.00105	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00093	0.00104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00093	0.00104	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000907	0.00102	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000904	0.00101	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000895	0.001	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000891	0.000998	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00088	0.000986	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000878	0.000983	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000869	0.000973	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00086	0.000963	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00086	0.000963	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000857	0.00096	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000857	0.00096	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000853	0.000955	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00085	0.000952	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000849	0.00095	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000849	0.00095	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000849	0.00095	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000842	0.000942	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000813	0.00091	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.0008	0.000895	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000797	0.000892	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000795	0.000891	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000789	0.000884	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000774	0.000867	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000772	0.000864	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000765	0.000857	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000764	0.000856	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000763	0.000854	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000762	0.000853	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00076	0.000851	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000753	0.000844	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000753	0.000844	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000728	0.000815	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000728	0.000815	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000726	0.000813	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000722	0.000809	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000722	0.000808	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000722	0.000808	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000719	0.000805	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.0007	0.000784	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000692	0.000774	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000691	0.000773	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00069	0.000773	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000689	0.000771	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000682	0.000764	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000678	0.00076	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000671	0.000751	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000661	0.00074	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000661	0.00074	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000659	0.000738	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000653	0.000731	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00065	0.000727	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000627	0.000702	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000625	0.0007	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000619	0.000693	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000579	0.000649	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000572	0.000641	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00057	0.000639	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000565	0.000632	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000555	0.000621	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00055	0.000615	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000536	0.0006	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000535	0.000599	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000529	0.000593	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000526	0.000589	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000512	0.000574	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000511	0.000572	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000508	0.000569	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000508	0.000569	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000506	0.000567	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000506	0.000567	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000506	0.000566	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000502	0.000561	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000502	0.000561	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000487	0.000545	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000486	0.000544	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000481	0.000538	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000479	0.000536	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000472	0.000529	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000472	0.000529	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000471	0.000527	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000466	0.000522	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000465	0.000521	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000464	0.000519	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000459	0.000514	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000459	0.000514	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000457	0.000512	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000456	0.00051	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000452	0.000506	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000452	0.000506	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000427	0.000478	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000409	0.000457	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000408	0.000456	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000391	0.000437	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.00039	0.000437	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000389	0.000436	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000386	0.000432	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000374	0.000418	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000371	0.000415	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000369	0.000414	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000366	0.00041	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000364	0.000408	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000328	0.000368	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000328	0.000367	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000323	0.000362	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000322	0.00036	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000319	0.000357	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000318	0.000357	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000317	0.000355	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000315	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000314	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000288	0.000322	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000287	0.000321	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000284	0.000318	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000283	0.000317	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000275	0.000308	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000274	0.000307	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000271	0.000304	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000271	0.000303	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000221	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000221	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000219	0.000245	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000194	0.000217	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000191	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00019	0.000213	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000188	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000186	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000131	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00013	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000129	0.000145	CbGpPWpGaD
